Iżrael - Ebrajk - Ministry of Health

j-c health care ltd - estradiol as hemihydrate 1.6 mg - patches - estradiol - deficiency symptoms by absence of estrogen after the menopause or after surgical removal of the ovarians. they comprise hot flushes, insomnia, atrophies of the urogenital system, changes of mood and increasing loss of the bone substance, which can lead to osteoporosis. in women with intact uterus, estrogen substitution must always be supplemented with a sequential gestagen therapy.

Iżrael - Ebrajk - Ministry of Health

j-c health care ltd - estradiol as hemihydrate 4.8 mg - patches - estradiol - deficiency symptoms by absence of estrogen after the menopause or after surgical removal of the ovarians. they comprise hot flushes, insomnia, atrophies of the urogenital system, changes of mood and increasing loss of the bone substance, which can lead to osteoporosis.in women with intact uterus, estrogen substitution must always be supplemented with a sequential gestagen therapy.

Iżrael - Ebrajk - Ministry of Health

j-c health care ltd - estradiol as hemihydrate 6.4 mg - patches - estradiol - deficiency symptoms by absence of estrogen after the menopause or after surgical removal of the ovarians. they comprise hot flushes, insomnia, atrophies of the urogenital system, changes of mood and increasing loss of the bone substance, which can lead to osteoporosis. in women with intact uterus, estrogen substitution must always be supplemented with a sequential gestagen therapy.

Iżrael - Ebrajk - Ministry of Health

bayer israel ltd - ethinylestradiol; gestodene - טבליות מצופות - ethinylestradiol 0.03 mg; gestodene 0.075 mg - ethinylestradiol - ethinylestradiol - hormonal contraception.

Iżrael - Ebrajk - Ministry of Health

organon pharma israel ltd., israel - ethinylestradiol; etonogestrel - טבעת וגינלית - ethinylestradiol 2.7 mg; etonogestrel 11.7 mg - ethinylestradiol - ethinylestradiol - contraception. the safety and efficacy has been established in women aged 18 to 40 years.

Iżrael - Ebrajk - Ministry of Health

dexcel ltd, israel - ethinylestradiol; gestodene - טבליה - ethinylestradiol 0.03 mg; gestodene 0.075 mg - ethinylestradiol - ethinylestradiol - contraceptive.

Iżrael - Ebrajk - Ministry of Health

dexcel ltd, israel - ethinylestradiol; gestodene - טבליה - ethinylestradiol 0.02 mg; gestodene 0.075 mg - ethinylestradiol - ethinylestradiol - contraceptive.

Iżrael - Ebrajk - Ministry of Health

novo nordisk ltd., israel - estradiol as hemihydrate - טבליות מצופות פילם - estradiol as hemihydrate 2 mg - estradiol - estradiol - hormone replacement therapy (hrt) for estrogen deficiency symptoms in postmenopausal women. prevention of osteoporosis in postmenopausal women at high risk of future fractures, who are tolerant of , or contraindicated for other medicinal products approved for the prevention of osteoporosis. estrofem is particularly for women who have been hysterectomized and therefore do not require combined estrogen/progestagen therapy.

Iżrael - Ebrajk - Ministry of Health

cts ltd - estradiol - ג'ל - estradiol 0.06 %w/w - estradiol - estradiol - hormonal replacement therapy for the treatment of symptoms associated with estrogen deficiency in menopausal women. prevention of postmenopausal osteoporosis in women with an increased risk for osteoporotic fractures and presenting intolerace or a contraindication to others treatments indicated in the prevention of osteoporosis.

Iżrael - Ebrajk - Ministry of Health

novo nordisk ltd., israel - estradiol as hemihydrate - טבליות מצופות פילם - estradiol as hemihydrate 1 mg - estradiol - estradiol - hormone replacement therapy (hrt) for estrogen deficiency symptoms in postmenopausal women. prevention of osteoporosis in postmenopausal women at high risk of future fractures, who are tolerant of , or contraindicated for other medicinal products approved for the prevention of osteoporosis. estrofem is particularly for women who have been hysterectomized and therefore do not require combined estrogen/progestagen therapy.